SCHEMBL7847466

SCHEMBL7847466

Nc1ncnc2c1c(-c1ccccc1)cn2-c1ccc(OCc2ccccc2)cc1

nearest known ligand 0.73

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SRC P12931 16/20 0.73
EGFR P00533 10/20 0.73
ABL1 P00519 9/20 0.73
ABL2 P42684 9/20 0.73
CDK1 P06493 6/20 0.73
KDR P35968 5/20 0.73
CSK P41240 2/20 0.64
POLB P06746 1/20 0.59
MAPT P10636 1/20 0.57
PIK3CD O00329 1/20 0.56
PIK3CA P42336 1/20 0.56
PIK3CB P42338 1/20 0.56
PIK3CG P48736 1/20 0.56
PRKDC P78527 1/20 0.56
INSR P06213 1/20 0.56
IGF1R P08069 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7833880 0.95 SRC (0.75) SRCEGFRABL1ABL2CDK1
SCHEMBL7835124 0.91 SRC (0.62) SRCEGFRABL1ABL2CDK1
SCHEMBL7845816 0.89 SRC (0.76) SRCEGFRABL1ABL2CDK1
SCHEMBL7844800 0.88 SRC (0.73) SRCEGFRABL1ABL2CDK1
SCHEMBL7844861 0.88 SRC (0.73) SRCEGFRABL1ABL2CDK1
SCHEMBL7848781 0.87 SRC (0.71) SRCEGFRABL1ABL2CDK1
SCHEMBL7844053 0.86 SRC (0.70) SRCEGFRABL1ABL2CDK1
SCHEMBL7845043 0.86 SRC (0.70) SRCEGFRABL1ABL2CDK1
SCHEMBL7844437 0.86 SRC (0.62) SRCEGFRABL1ABL2CDK1
Dimethylamine SCHEMBL7844070 0.86 SRC (0.64) SRCEGFRABL1ABL2CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0783505-B1 PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE NOVARTIS AG (CH) 2001-03-07 EP disclosed
EP-0783505-A1 PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE Novartis AG (CH) 1997-07-16 EP disclosed
WO-1996010028-A1 PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE NOVARTIS AG (CH) 1996-04-04 WO disclosed